[144] Kulicke & Soffa Industries Inc SEC Filing

Rhea-AI Filing Summary

Kulicke & Soffa Industries (KLIC) has a Form 144 notice reporting a proposed sale of 30,000 common shares through Apex Clearing on the Nasdaq with an aggregate market value of $1,095,600.00. The shares were acquired on 06/02/2022 and the filer lists an approximate sale date of 08/12/2025. The filing indicates no reported sales of the issuer’s securities by the filer in the past three months.

The notice includes the filer’s representation that they are not aware of any undisclosed material adverse information about the issuer. This is a routine Rule 144 notification describing the shares, broker, acquisition details, and planned sale date.

Insights

Securities Analyst

TL;DR: Routine Rule 144 insider sale notice for 30,000 KLIC shares, not inherently material to valuation.

The filing documents a proposed sale of 30,000 shares of common stock with an aggregate market value of $1,095,600, to be executed via Apex Clearing on Nasdaq. The shares were acquired on 06/02/2022, and no sales by the filer were reported in the prior three months. As a Securities Analyst, I view this as a standard disclosure under Rule 144; absent additional context about the holder’s role or larger selling patterns, the position size relative to total outstanding shares (52,145,526) appears small, suggesting limited immediate market impact.

Corporate Governance Expert

TL;DR: Disclosure aligns with regulatory requirements; filer affirms no undisclosed material adverse information.

The notice includes the filer’s signed representation that they do not possess undisclosed material adverse information regarding the issuer. From a governance perspective, the form fulfills Rule 144 reporting obligations by identifying acquisition date, broker, planned sale date, and share quantity. This filing alone does not signal governance concerns but should be reviewed in context with other insider activity for a fuller assessment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST SUITE 300 DALLAS TX 75201	30000	1095600.00	52145526	08/12/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/02/2022	Owned Shares	Kulicke and Soffa Industries, Inc.			30000	08/12/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many KLIC shares are proposed for sale in this Form 144?

The filing proposes the sale of 30,000 common shares.

What is the aggregate market value of the shares listed in the KLIC Form 144?

The aggregate market value reported is $1,095,600.00.

When were the shares acquired and what is the planned sale date?

The shares were acquired on 06/02/2022 and the approximate sale date is 08/12/2025.

Which broker and exchange are named in the Form 144 for KLIC?

The broker is Apex Clearing (350 N St. Paul St, Suite 300, Dallas, TX 75201) and the sale is listed for Nasdaq.

Did the filer report any KLIC securities sold in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filer assert knowledge of any undisclosed material information about KLIC?

The filer represents by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.